DFX Intelligence
Data Factory
Reading the graph
Reading the graph
advised by NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
Cayman Islands
Data as of (this record's last observation) from federal regulator filings. Page built and rebuilt at most every 15 minutes.
| Filed | GAV | Owners | Minimum | Adviser owns | Audited | Name as filed |
|---|---|---|---|---|---|---|
| Oct 11, 2024 | $48.1M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Sep 3, 2024 | $48.1M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Apr 15, 2024 | $48.1M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 29, 2024 | $48.1M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Feb 29, 2024 | $57.6M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Nov 20, 2023 | $57.6M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Aug 1, 2023 | $57.6M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Jun 8, 2023 | $57.6M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 31, 2023 | $57.6M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 31, 2022 | $96.2M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Jun 30, 2021 | $130M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 30, 2021 | $130M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Jun 11, 2020 | $190M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| May 15, 2020 | $190M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 30, 2020 | $190M | 14 | $10.0M | 600.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 31, 2019 | $239M | 14 | $10.0M | 500.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 29, 2018 | $446M | 15 | $10.0M | 500.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Sep 26, 2017 | $474M | 15 | $10.0M | 500.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 30, 2017 | $474M | 15 | $10.0M | 500.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 30, 2016 | $544M | 15 | $10.0M | 500.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 24, 2015 | $455M | 15 | $10.0M | 500.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Apr 16, 2014 | $477M | 15 | $10.0M | 500.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Mar 27, 2014 | $477M | 15 | $10.0M | 500.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Apr 1, 2013 | $62.8M | 9 | $10.0M | 1400.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Jun 15, 2012 | $29.1M | 8 | $10.0M | 3300.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Apr 17, 2012 | $29.1M | 8 | $10.0M | 3300.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Feb 14, 2012 | $29.1M | 8 | $10.0M | 3300.0% | yes | NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P. |
| Custodian | Legal name | City | State | Country | Related person | SEC number |
|---|---|---|---|---|---|---|
| MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED | MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED | SAN FRANCISCO | California | United States | no | 8-7221 |
| SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK | SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK | Boston | Massachusetts | United States | no | n/a |
| WELLS FARGO BANK, N.A. | WELLS FARGO BANK, N.A. | Raleigh | North Carolina | United States | no | n/a |